BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
BiohacksAI/Conditions/Hypertension
CONDITION

Evidence-Based Compounds for Hypertension

Hypertension involves impaired nitric oxide bioavailability, renin-angiotensin system dysregulation, oxidative stress, and endothelial dysfunction. Compounds with clinical evidence for reducing systolic and diastolic blood pressure through NO pathway support, vasodilation, and ACE inhibition are ranked by evidence strength.

NITRIC OXIDE pathway →INFLAMMATION pathway →OXIDATIVE STRESS pathway →
Top 4 Compounds — Ranked by Evidence
Weighted ranking: BiohacksAI discovery score · pathway overlap · PubMed study count
1
Berberinefeatured
300+
studies
2
Coenzyme Q10featured
coenzyme
3
Magnesiumfeatured
293+
studies
4
Vitamin Dfeatured
294+
studies
Ranking Methodology
Compounds are ranked using a four-signal weighted model: BiohacksAI discovery score (cross-study convergence across targets), target match (direct overlap with NOS3, ACE, AGTR1 and related targets — highest differentiating signal), pathway overlap with NITRIC OXIDE and INFLAMMATION pathways, and PubMed study count (log-scaled). Clinical drugs are excluded.
Key Biological Targets
NOS3ACEAGTR1PTGS2EDN1

Click a target to see all compounds with documented interactions in the BiohacksAI corpus.

Related Health Goals
Best compounds for longevity →Best compounds for inflammation →Best compounds for stress →
Related Conditions
Metabolic SyndromeChronic InflammationDiabetes

This page presents computational analysis of published research from PubMed/NCBI, BindingDB, and Reactome. Rankings are based on BiohacksAI discovery score, pathway overlap, and study count. This is not medical advice — consult a healthcare professional before starting any supplement.

Browse all compounds · Biological pathways · Molecular targets · All conditions

© Organiq Sweden AB · Patent pending EVE-PAT-2026-001